Chart-Typ:
Zeitraum:
| JNJ's Icotrokinra Shows Positive Phase 3 Results In Scalp, Genital Psoriasis | NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) Friday reported positive Phase 3 ICONIC-TOTAL data for Icotrokinra, a once-daily oral peptide that selectively inhibits the IL-23 receptor.... ► Artikel lesen |
| Johnson & Johnson: Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis | 66% of patients with scalp psoriasis and 77% with genital psoriasis treated with investigational icotrokinra achieved site-specific clear or almost clear skin at... ► Artikel lesen |
| ACTO Technologies, Inc.: ACTO APPOINTS FORMER J&J PRESIDENT TO ITS BOARD OF DIRECTORS | Lori Tierney Brings Vast Expertise and Experience to Help ACTO Lead the Life Sciences Industry Towards an AI-First Future
TORONTO and NEW YORK, May 8, 2025 /PRNewswire/ -- ACTO, the... ► Artikel lesen |
| Leichter Wertverlust bei der Moderna-Aktie (21,7192 €) | Die Aktie von Moderna notiert am Mittwoch ein wenig leichter. Die Aktie kostete zuletzt 24,34 US-Dollar. An der Börse liegt der Anteilsschein von Moderna derzeit im Minus. Das Wertpapier verbilligte... ► Artikel lesen |
| Moderna, Inc.: Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference on May 29, 2025 | CAMBRIDGE, MA / ACCESS Newswire / May 8, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:Bernstein's 41st Annual Strategic Decisions... ► Artikel lesen |
| Benchling and Moderna Collaborate on AI-Driven Research | SAN FRANCISCO and BOSTON, May 7, 2025 /PRNewswire/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling... ► Artikel lesen |
| Rznomics Inc.: Rznomics Enters Global Licensing Agreement with Eli Lilly for RNA-editing Therapeutics | Co-development of precision RNA therapeutics for inherited hearing loss treatmentSEONGNAM, South Korea, May 15, 2025 /PRNewswire/ -- Rznomics Inc., a South Korea-based biopharmaceutical company... ► Artikel lesen |
| Male-Focused Weight Loss by the Specialists at The Naderi Center Using Zepbound | With Zepbound at Its Core, The Naderi Center's New Initiative Addresses Male Weight Loss and Facial Rejuvenation Through Physician-Led, Individualized Care RESTON, VIRGINIA / ACCESS Newswire / May 15... ► Artikel lesen |
| US-Inflationsdaten voraus! Bayer, Rheinmetall, Xiaomi, Amazon, Meta Platforms, Eli Lilly | Der DAX hat gestern ein Wechselbad der Gefühle erlebt. Kurz nach Handelsstart stieg er erstmals über 23.900 Punkte. Dann rutschte er im Lauf des Tages in die Verlustzone, beendete den Tag aber trotzdem... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACUTUS MEDICAL INC finden Sie auf Wallstreet Online.